Skip to main content
Log in

Schmerzen bei zervikaler Dystonie

Pain and cervical dystonia

  • Schwerpunkt
  • Published:
Der Schmerz Aims and scope Submit manuscript

Zusammenfassung

Hintergrund

Als Dystonien werden hyperkinetische Bewegungsstörungen bezeichnet, die durch anhaltende oder intermittierende Muskelkontraktionen zu Verdrehungen, Verkrampfungen und Tremor führen. Die zervikale Dystonie ist die häufigste Dystonieform, sie betrifft den Kopf‑, Hals- und/oder Schulterbereich. Neben diesen motorischen Symptomen sind Schmerzen und psychiatrische Symptome bei (zervikalen) Dystonien häufig.

Fragestellung

Beschreibung des Vorkommens und der Evaluation von Schmerzen bei zervikaler Dystonie, Zusammenfassung und Diskussion der Behandlungsmöglichkeiten und -wirkungen.

Material und Methoden

Im vorliegenden Übersichtsbeitrag werden die Erkenntnisse aus der wissenschaftlichen Fachliteratur zu Schmerzen bei Dystonien zusammengefasst und diskutiert.

Ergebnisse

Im Vergleich zu anderen Dystonieformen treten Schmerzen bei Patienten mit einer zervikalen Dystonie am häufigsten auf. Ein Großteil der Patienten mit einer zervikalen Dystonie leidet unter Schmerzen. Diese tragen am meisten zur Beeinträchtigung der Patienten bei. Die motorischen Symptome werden meist mit Botulinumtoxininjektionen behandelt. Diese wirken muskelentspannend und zudem auch schmerzlindernd. Die Studienlage zum Vorkommen und zur Therapie von Schmerzen bei anderen Dystonieformen ist bislang sehr limitiert. Der Schmerz kann bei Patienten mit einer zervikalen Dystonie im Vordergrund des Krankheitsbilds stehen. Die Evaluation von Schmerzen bei zervikalen Dystonien kann mittels standardisierter Fragebögen durchgeführt werden.

Schlussfolgerungen

Es ist wichtig, Patienten mit zervikaler Dystonie zu Schmerzen zu befragen und diese in der Therapieplanung und -evaluation zu berücksichtigen. Umgekehrt sollte bei Schmerzen auch an eine Dystonie als mögliche Ursache gedacht werden. Zur Evaluation gibt es teils neu entwickelte Fragebögen, um Schmerzen bei Patienten mit Dystonien standardisiert zu erfassen. Weitere Forschung ist nötig, um die Pathomechanismen der Schmerzen bei Dystonien besser zu verstehen.

Abstract

Background

Dystonia is a hyperkinetic movement disorder that results in twisting, cramps and tremors due to sustained or intermittent muscle contractions. Cervical dystonia is the most common form of dystonia, in which the head, neck and/or shoulder areas are affected. In addition to these motor symptoms, pain and psychiatric symptoms are frequent in (cervical) dystonia.

Objective

Description of the incidence and evaluation of pain in cervical dystonia, summary and discussion of treatment options and effects.

Material and methods

In this review article the results in the scientific literature on pain in dystonia are summarized and discussed.

Results

Compared to other forms of dystonia, pain occurs most frequently in patients with cervical dystonia. A large proportion of patients with cervical dystonia suffer from pain, which contributes most to impairment of the patient. The motor symptoms of dystonia are usually treated with botulinum toxin injections. These have a muscle relaxing effect and also relieve pain. The study situation on the occurrence and treatment of pain in other forms of dystonia is so far very limited. Pain can dominate the clinical picture in patients with cervical dystonia. Evaluation of pain in cervical dystonia can be performed using standardized questionnaires.

Conclusion

It is important to ask patients with cervical dystonia about pain and to consider it in treatment planning and evaluation. Vice versa, if pain is present the possibility of a causative dystonia should also be considered. For pain assessment there are some newly developed questionnaires to assess pain in a standardized way in patients with dystonia. Further research is needed to better understand the pathomechanisms of pain in dystonia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Albanese A, Asmus F, Bhatia KP et al (2011) EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 18:5–18. https://doi.org/10.1111/j.1468-1331.2010.03042.x

    Article  CAS  PubMed  Google Scholar 

  2. Albanese A, Bhatia K, Bressman SB et al (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord Off J Mov Disord Soc 28:863–873. https://doi.org/10.1002/mds.25475

    Article  Google Scholar 

  3. Albanese A, Sorbo FD, Comella C et al (2013) Dystonia rating scales: critique and recommendations. Mov Disord 28:874–883. https://doi.org/10.1002/mds.25579

    Article  PubMed  PubMed Central  Google Scholar 

  4. Anis S, Faust-Socher A, Sverdlov D et al (2023) A single-center real-life study on the use of medical cannabis in patients with dystonia. Front Neurol 14:1218300. https://doi.org/10.3389/fneur.2023.1218300

    Article  PubMed  PubMed Central  Google Scholar 

  5. Avenali M, De Icco R, Tinazzi M et al (2018) Pain in focal dystonias—a focused review to address an important component of the disease. Parkinsonism Relat Disord 54:17–24. https://doi.org/10.1016/j.parkreldis.2018.04.030

    Article  PubMed  Google Scholar 

  6. Barbanti P, Fabbrini G, Pauletti C et al (2005) Headache in cranial and cervical dystonia. Neurology 64:1308–1309. https://doi.org/10.1212/01.WNL.0000156909.13677.FF

    Article  CAS  PubMed  Google Scholar 

  7. Bega D, Park K, Grimone A et al (2018) Acupuncture as aadjuvant tfor the management of cervical dystonia. Med Acupunct 30:198–203. https://doi.org/10.1089/acu.2018.1291

    Article  PubMed  PubMed Central  Google Scholar 

  8. Bradley D, Whelan R, Walsh R et al (2009) Temporal discrimination threshold: VBM evidence for an endophenotype in adult onset primary torsion dystonia. Brain J Neurol 132:2327–2335. https://doi.org/10.1093/brain/awp156

    Article  CAS  Google Scholar 

  9. Bruno V, Achen B, Morgante F et al (2023) The Pain in Dystonia Scale (PIDS)—development and validation in cervical dystonia. Mov Disord 38:1175–1186. https://doi.org/10.1002/mds.29452

    Article  PubMed  Google Scholar 

  10. Cano SJ, Warner TT, Linacre JM et al (2004) Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58). Neurology 63:1629–1633. https://doi.org/10.1212/01.wnl.0000142962.11881.26

    Article  CAS  PubMed  Google Scholar 

  11. Casale R, Tugnoli V (2008) Botulinum toxin for pain. Drugs 9:11–27. https://doi.org/10.2165/00126839-200809010-00002

    Article  CAS  Google Scholar 

  12. Castelão M, Marques RE, Duarte GS et al (2017) Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 12:CD3633. https://doi.org/10.1002/14651858.CD003633.pub3

    Article  PubMed  Google Scholar 

  13. Chan J, Brin MF, Fahn S (1991) Idiopathic cervical dystonia: clinical characteristics. Mov Disord Off J Mov Disord Soc 6:119–126. https://doi.org/10.1002/mds.870060206

    Article  CAS  Google Scholar 

  14. Charles PD, Adler CH, Stacy M et al (2014) Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy). J Neurol 261:1309–1319. https://doi.org/10.1007/s00415-014-7343-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Comella C, Bhatia K (2015) An international survey of patients with cervical dystonia. J Neurol 262:837–848. https://doi.org/10.1007/s00415-014-7586-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Comella C, Ferreira JJ, Pain E et al (2021) Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia. J Neurol 268:903–912. https://doi.org/10.1007/s00415-020-10217-7

    Article  PubMed  Google Scholar 

  17. Consky ES (1990) The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS): assessment of validity and inter-rater reliability. Neurology 40:445

    Google Scholar 

  18. De Pauw J, Van der Velden K, Meirte J et al (2014) The effectiveness of physiotherapy for cervical dystonia: a systematic literature review. J Neurol 261:1857–1865. https://doi.org/10.1007/s00415-013-7220-8

    Article  PubMed  Google Scholar 

  19. Deepak R, Mathew H, Koshy M (2010) Effectiveness of acupuncture in cervical dystonia. Acupunct Med J Br Med Acupunct Soc 28:94–96. https://doi.org/10.1136/aim.2009.002048

    Article  Google Scholar 

  20. Defazio G, Abbruzzese G, Livrea P, Berardelli A (2004) Epidemiology of primary dystonia. Lancet Neurol 3:673–678. https://doi.org/10.1016/S1474-4422(04)00907-X

    Article  PubMed  Google Scholar 

  21. van den Dool J, Tijssen MJ, Koelman MJJHTM et al (2016) Determinants of disability in cervical dystonia. Parkinsonism Relat Disord 32:48–53. https://doi.org/10.1016/j.parkreldis.2016.08.014

    Article  PubMed  Google Scholar 

  22. Dworkin RH, Turk DC, Farrar JT et al (2005) Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113:9–19. https://doi.org/10.1016/j.pain.2004.09.012

    Article  PubMed  Google Scholar 

  23. Faircloth S, Reid S (2006) A cognitive–behavioural approach to the management of idiopathic cervical dystonia. J Behav Ther Exp Psychiatry 37:239–246. https://doi.org/10.1016/j.jbtep.2005.07.003

    Article  PubMed  Google Scholar 

  24. Han V, Skorvanek M, Smit M et al (2020) Prevalence of non-motor symptoms and their association with quality of life in cervical dystonia. Acta Neurol Scand 142:613–622. https://doi.org/10.1111/ane.13304

    Article  PubMed  Google Scholar 

  25. Hefter H, Benecke R, Erbguth F et al (2013) An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport). BMJ Open 3:e1853. https://doi.org/10.1136/bmjopen-2012-001853

    Article  PubMed  PubMed Central  Google Scholar 

  26. Ip CW, Bäumer T, Ceballos-Baumann A et al (2021) Dystonie, S1-leitlinie

    Google Scholar 

  27. Jankovic J, Leder S, Warner D, Schwartz K (1991) Cervical dystonia: clinical findings and associated movement disorders. Neurology 41:1088–1088. https://doi.org/10.1212/WNL.41.7.1088

    Article  CAS  PubMed  Google Scholar 

  28. Klein C, Fahn S (2013) Translation of Oppenheim’s 1911 paper on dystonia. Mov Disord Off J Mov Disord Soc 28:851–862. https://doi.org/10.1002/mds.25546

    Article  Google Scholar 

  29. Klingelhoefer L, Kaiser M, Sauerbier A et al (2021) Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia. J Neural Transm 1996(128):305–314. https://doi.org/10.1007/s00702-020-02274-z

    Article  CAS  Google Scholar 

  30. Kulenkamp J, McClelland CM, Lee MS (2020) Eye pain in the white and quiet eye. Curr Opin Ophthalmol 31:483–488. https://doi.org/10.1097/ICU.0000000000000702

    Article  PubMed  Google Scholar 

  31. Kutvonen O, Dastidar P, Nurmikko T (1997) Pain in spasmodic torticollis. Pain 69:279–286. https://doi.org/10.1016/S0304-3959(96)03296-4

    Article  CAS  PubMed  Google Scholar 

  32. Medina A, Nilles C, Martino D, Pelletier C, Pringsheim T (2022) The prevalence of idiopathic or inherited isolated dystonia: a systematic review and meta-analysis. Mov Disord Clin Pract 9(7):860–868. https://doi.org/10.1002/mdc3.13524

    Article  PubMed  PubMed Central  Google Scholar 

  33. Lalli S, Albanese A (2010) The diagnostic challenge of primary dystonia: evidence from misdiagnosis. Mov Disord Off J Mov Disord Soc 25:1619–1626. https://doi.org/10.1002/mds.23137

    Article  Google Scholar 

  34. Lim K, See YM, Lee J (2017) A systematic review of the effectiveness of medical cannabis for psychiatric, movement and neurodegenerative disorders. Clin Psychopharmacol Neurosci Off Sci J Korean Coll Neuropsychopharmacol 15:301–312. https://doi.org/10.9758/cpn.2017.15.4.301

    Article  CAS  Google Scholar 

  35. Listik C, Listik E, de Paiva Santos Rolim F et al (2023) Development and validation of the dystonia-pain classification system: a multicenter study. Mov Disord 38:1163–1174. https://doi.org/10.1002/mds.29423

    Article  CAS  PubMed  Google Scholar 

  36. Lobbezoo F, Tanguay R, Thon MT, Lavigne GJ (1996) Pain perception in idiopathic cervical dystonia (spasmodic torticollis). Pain 67:483–491. https://doi.org/10.1016/0304-3959(96)03153-3

    Article  CAS  PubMed  Google Scholar 

  37. Lobbezoo F, Thu Thon M, Rémillard G et al (1996) Relationship between sleep, neck muscle activity, and pain in cervical dystonia. Can J Neurol Sci J Can Sci Neurol 23:285–290. https://doi.org/10.1017/s0317167100038233

    Article  CAS  Google Scholar 

  38. Macerollo A, Sajin V, Bonello M et al (2020) Deep brain stimulation in dystonia: state of art and future directions. J Neurosci Methods 340:108750. https://doi.org/10.1016/j.jneumeth.2020.108750

    Article  CAS  PubMed  Google Scholar 

  39. Marciniec M, Szczepańska-Szerej A, Papuć E, Rejdak K (2022) Targeting pain in the long-term treatment of cervical dystonia with botulinum toxin A. Int J Neurosci 132:1026–1030. https://doi.org/10.1080/00207454.2020.1860039

    Article  CAS  PubMed  Google Scholar 

  40. Mascia MM, Carmagnini D, Defazio G (2020) Cannabinoids and dystonia: an issue yet to be defined. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 41:783–787. https://doi.org/10.1007/s10072-019-04196-5

    Article  Google Scholar 

  41. Muller J, Wissel J, Kemmler G et al (2004) Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psychiatry 75:749–753. https://doi.org/10.1136/jnnp.2003.013441

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Newby R, Muhamed S, Alty J et al (2022) Geste antagoniste effects on motor performance in dystonia—a kinematic study. Mov Disord Clin Pract 9:759–764. https://doi.org/10.1002/mdc3.13505

    Article  PubMed  PubMed Central  Google Scholar 

  43. Novaretti N, Cunha ALN, Bezerra TC et al (2019) The prevalence and correlation of non-motor symptoms in adult patients with idiopathic focal or segmental dystonia. Tremor Hyperkinetic Mov N Y N 9:596. https://doi.org/10.7916/fhnv-v355

    Article  Google Scholar 

  44. Ondo WG, Gollomp S, Galvez-Jimenez N (2005) A pilot study of botulinum toxin A for headache in cervical dystonia. Headache 45:1073–1077. https://doi.org/10.1111/j.1526-4610.2005.05190.x

    Article  PubMed  Google Scholar 

  45. Pelosin E, Avanzino L, Marchese R et al (2013) kinesiotaping reduces pain and modulates sensory function in patients with focal dystonia: a randomized crossover pilot study. Neurorehabil Neural Repair 27:722–731. https://doi.org/10.1177/1545968313491010

    Article  PubMed  Google Scholar 

  46. Relja M, Miletić V (2017) When movement disorders hurt: addressing pain in hyperkinetic disorders. Parkinsonism Relat Disord 44:110–113. https://doi.org/10.1016/j.parkreldis.2017.08.011

    Article  PubMed  Google Scholar 

  47. Richter T, Nestler-Parr S, Babela R et al (2015) Rare disease terminology and definitions—a systematic global review: report of the ISPOR rare disease special interest group. Value Health J Int Soc Pharmacoeconomics Outcomes Res 18:906–914. https://doi.org/10.1016/j.jval.2015.05.008

    Article  Google Scholar 

  48. Rodrigues FB, Duarte GS, Marques RE et al (2020) Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 11:CD3633. https://doi.org/10.1002/14651858.CD003633.pub4

    Article  PubMed  Google Scholar 

  49. Rodrigues FB, Duarte GS, Prescott D et al (2019) Deep brain stimulation for dystonia. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD012405.pub2

    Article  PubMed  PubMed Central  Google Scholar 

  50. Rosales RL, Cuffe L, Regnault B, Trosch RM (2021) Pain in cervical dystonia: mechanisms, assessment and treatment. Expert Rev Neurother 21:1125–1134. https://doi.org/10.1080/14737175.2021.1984230

    Article  CAS  PubMed  Google Scholar 

  51. Sheehy MP, Marsden CD (1980) Trauma and pain in spasmodic torticollis. Lancet Lond Engl 1:777–778. https://doi.org/10.1016/s0140-6736(80)91281-7

    Article  CAS  Google Scholar 

  52. Smit M, Kuiper A, Han V et al (2016) Psychiatric co-morbidity is highly prevalent in idiopathic cervical dystonia and significantly influences health-related quality of life: results of a controlled study. Parkinsonism Relat Disord 30:7–12. https://doi.org/10.1016/j.parkreldis.2016.06.004

    Article  CAS  PubMed  Google Scholar 

  53. Tinazzi M, Erro R, Mascia MM et al (2020) Demographic and clinical determinants of neck pain in idiopathic cervical dystonia. J Neural Transm Vienna Austria 1996(127):1435–1439. https://doi.org/10.1007/s00702-020-02245-4

    Article  Google Scholar 

  54. Tinazzi M, Squintani GM, Bhatia KP et al (2019) Pain in cervical dystonia: evidence of abnormal inhibitory control. Parkinsonism Relat Disord 65:252–255. https://doi.org/10.1016/j.parkreldis.2019.06.009

    Article  PubMed  Google Scholar 

  55. Trosch RM, Espay AJ, Truong D et al (2017) Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: the ANCHOR-CD registry. J Neurol Sci 376:84–90. https://doi.org/10.1016/j.jns.2017.02.042

    Article  CAS  PubMed  Google Scholar 

  56. Vu JP, Lee HY, Chen Q et al (2021) Head tremor and pain in cervical dystonia. J Neurol 268:1945–1950. https://doi.org/10.1007/s00415-020-10378-5

    Article  PubMed  PubMed Central  Google Scholar 

  57. Wadon ME, Bailey GA, Yilmaz Z et al (2021) Non-motor phenotypic subgroups in adult-onset idiopathic, isolated, focal cervical dystonia. Brain Behav 11:e2292. https://doi.org/10.1002/brb3.2292

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Wadon ME, Winter M, Peall KJ (2020) Internet-based cognitive behavioural therapy programme as an intervention for people diagnosed with adult-onset, focal, isolated, idiopathic cervical dystonia: a feasibility study protocol. Pilot Feasibility Stud 6:100. https://doi.org/10.1186/s40814-020-00641-x

    Article  PubMed  PubMed Central  Google Scholar 

  59. Weissbach A, Pauly MG, Herzog R et al (2022) Relationship of Genotype, Phenotype, and Treatment in Dopa-Responsive Dystonia: MDSGene Review. Mov Disord Off J Mov Disord Soc 37:237–252. https://doi.org/10.1002/mds.28874

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tobias Bäumer.

Ethics declarations

Interessenkonflikt

T. Bäumer: Referententätigkeit für Pharmazeutische Unternehmen, die Botulinumtoxin herstellen. F. Hamami gibt an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Hinweis des Verlags

Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hamami, F., Bäumer, T. Schmerzen bei zervikaler Dystonie. Schmerz 38, 41–47 (2024). https://doi.org/10.1007/s00482-024-00790-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00482-024-00790-5

Schlüsselwörter

Keywords

Navigation